Bio-Rad Laboratories (BIO-B) FCF Margin (2009 - 2026)
Bio-Rad Laboratories (BIO-B) reported FCF Margin of 13.19% for Q1 2026, down 312.0% year-over-year from 6.22% in Q1 2025, and down 23.23% on a QoQ basis from 17.18% in Q4 2025.
Bio-Rad Laboratories (BIO-B) has 18 years of FCF Margin data on file, last reported at 13.19% in Q1 2026.
- Quarterly FCF Margin fell 312.0% year-over-year to 13.19% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.79% (down 20.0% YoY) and the FY2025 annual result came in at 14.5%, up 322.0% from the prior year.
- FCF Margin retreated to 13.19% in Q1 2026 per BIO-B's latest filing, from 17.18% in the prior quarter.
- Across five years, FCF Margin topped out at 18.99% in Q3 2024 and bottomed at 2.44% in Q3 2022.
- The 5-year median for FCF Margin is 9.22% (2023), against an average of 9.41%.
- The widest annual swing landed in 2022, when FCF Margin tumbled 2864 bps; it then surged 1147 bps in 2025.
- Tracing BIO-B's FCF Margin over 5 years: stood at 6.13% in 2022, then decreased by 7 bps to 5.69% in 2023, then soared by 114 bps to 12.18% in 2024, then soared by 41 bps to 17.18% in 2025, then slipped by 23 bps to 13.19% in 2026.
- Per Business Quant, the three latest BIO-B FCF Margin figures stand at 13.19% (Q1 2026), 17.18% (Q4 2025), and 13.66% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | 13.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.19% |
| Dec 31, 2025 | 17.18% |
| Sep 30, 2025 | 13.66% |
| Jun 30, 2025 | 10.87% |
| Mar 31, 2025 | 16.31% |
| Dec 31, 2024 | 12.18% |
| Sep 30, 2024 | 18.99% |
| Jun 30, 2024 | 8.66% |
| Mar 31, 2024 | 4.85% |
| Dec 31, 2023 | 5.69% |
| Sep 30, 2023 | 8.49% |
| Jun 30, 2023 | 9.31% |
| Mar 31, 2023 | 9.22% |
| Dec 31, 2022 | 6.13% |
| Sep 30, 2022 | -2.44% |
| Jun 30, 2022 | 5.20% |
| Mar 31, 2022 | 2.49% |
| Dec 31, 2021 | 15.66% |
| Sep 30, 2021 | 26.21% |
| Jun 30, 2021 | 18.33% |
| Mar 31, 2021 | 12.94% |
| Dec 31, 2020 | 31.08% |
| Sep 30, 2020 | 17.87% |
| Jun 30, 2020 | 13.78% |
| Mar 31, 2020 | 7.21% |
| Dec 31, 2019 | 22.13% |
| Sep 30, 2019 | 12.26% |
| Jun 30, 2019 | 23.26% |
| Mar 31, 2019 | 3.48% |
| Dec 31, 2018 | -4.02% |
| Sep 30, 2018 | 11.42% |
| Jun 30, 2018 | 18.24% |
| Mar 31, 2018 | 2.39% |
| Dec 31, 2017 | 6.96% |
| Sep 30, 2017 | 1.53% |
| Jun 30, 2017 | 14.09% |
| Mar 31, 2017 | -25.94% |
| Dec 31, 2016 | -8.16% |
| Sep 30, 2016 | 10.14% |
| Jun 30, 2016 | 16.79% |
| Mar 31, 2016 | -3.63% |
| Dec 31, 2015 | 1.39% |
| Sep 30, 2015 | 0.18% |
| Jun 30, 2015 | 12.45% |
| Mar 31, 2015 | 0.50% |
| Dec 31, 2014 | 6.56% |
| Sep 30, 2014 | 16.78% |
| Jun 30, 2014 | 10.70% |
| Mar 31, 2014 | 8.44% |
| Dec 31, 2013 | 7.10% |
| Sep 30, 2013 | 6.83% |
| Jun 30, 2013 | -0.91% |
| Mar 31, 2013 | -2.02% |
| Sep 30, 2012 | 6.95% |
| Jun 30, 2012 | 6.39% |
| Mar 31, 2012 | 0.12% |
| Dec 31, 2011 | 8.33% |
| Sep 30, 2011 | 5.13% |
| Jun 30, 2011 | 16.40% |
| Mar 31, 2011 | 0.41% |
| Dec 31, 2010 | 12.78% |
| Sep 30, 2010 | 9.86% |
| Jun 30, 2010 | -3.40% |
| Mar 31, 2010 | 8.52% |
| Dec 31, 2009 | -0.25% |
| Sep 30, 2009 | 24.51% |